Anzeige
Mehr »
Dienstag, 25.08.2026 - Börsentäglich über 12.000 News
NurExone Biologic: Der CEO legt die Karten auf den Tisch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
690 Leser
Artikel bewerten:
(2)

Bioz, Inc.: Gold Biotechnology Enhances Visibility and Engagement Through Bioz Partnership

PALO ALTO, CA / ACCESSWIRE / November 26, 2024 / Bioz, Inc., an innovator of AI-powered scientific citation management services, is proud to announce its continued partnership with Gold Biotechnology, a highly respected leader in the field of biological research products. Having collaborated for several years, GoldBio has successfully integrated Bioz's advanced solutions, including Bioz Badges and the Bioz Content Hub, to enhance their visibility and user engagement across the global research community.

Through this ongoing partnership, GoldBio is leveraging Bioz's powerful tools to showcase their innovative products. The Bioz Prime Badges serve as a visual endorsement, highlighting the quality and impact of GoldBio's offerings by displaying how frequently their products are cited in reputable scientific publications. Each badge includes critical citation data, enabling researchers to quickly assess the credibility and relevance of GoldBio's solutions in their specific fields of research.

By clicking on elements within Bioz Prime Badges, users can access detailed information about research that references GoldBio's products, offering insights into their applications and effectiveness. The badges not only enhance trust among researchers but also streamline the decision-making process when selecting tools for experiments.

Additionally, GoldBio's Content Hub complements the Prime Badges by providing an intuitive platform where users can explore a comprehensive collection of relevant research citations. The Content Hub aggregates citations in an organized manner, allowing researchers to easily navigate and discover the scientific studies that validate GoldBio's products. This enriched research experience empowers scientists to make informed decisions, ultimately driving greater engagement with Gold Biotechnology's offerings.

Marketing Director at GoldBio, Katharine Martin, expressed her enthusiasm for the collaboration, stating, "Working with Bioz has been a game-changer for us. Their solutions have provided invaluable insights and significantly enhanced our engagement with researchers. The feedback we've received from our users has been overwhelmingly positive, and our internal teams find the tools extremely useful." Chris Menne, Director of Website Development, added, "The integration of Bioz's tools into our website has been instrumental in improving how we connect with researchers. Bioz Prime Badges and the Bioz Content Hub are seamlessly integrated into our digital experience, allowing users to easily access key research data that highlights the quality and impact of our products. We've seen a noticeable increase in user engagement, and it's been great to see how these tools have enhanced the experience for our customers."

Dr. Karin Lachmi, Chief Revenue Officer and Co-Founder of Bioz, added, "We are thrilled to continue our partnership with GoldBio. Their commitment to quality products aligns perfectly with our mission to support the research community. By utilizing our Prime Badges and Content Hub, GoldBio is able to highlight their exceptional offerings, making it easier for researchers to find and validate the tools they need for their work."

About Bioz
Bioz is the world's most advanced AI search engine for scientific experimentation, offering evidence-based product ratings and recommendations to guide scientists toward the most validated products for their research. Bioz's solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.

About Gold Biotechnology
GoldBio is a leader in high-quality biological research products, specializing in reliable reagents, competent cells, research antibiotics, and enzymes for molecular biology, biochemistry, and cell culture. Committed to innovation, the company actively engages with researchers to refine its extensive product line, which includes competent cells, plasmids, bioluminescence substrates, cell culture media, and protein analysis reagents. GoldBio facilitates groundbreaking discoveries in life sciences and advances research in genomics, molecular biology, and proteomics.

Helpful Links

  • Bioz

  • Bioz Badges

  • Bioz Stars

  • Gold Biotechnology

For more information on Bioz solutions for suppliers, please reach out to info@bioz.com.

Contact Information

Daniel Levitt
CEO
pr@bioz.com

SOURCE: Bioz, Inc.

.

Source: Bioz, Inc.

© 2024 ACCESS Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.